Author(s): Vishal R Tandon, Zaffar Abbas, Samina Farhat, Zorawar Singh, Shakeel A. Mir, Muzaffer A. Pukhta
Journal: JK Science : Journal of Medical Education & Research
ISSN 0972-1177
Volume: 11;
Issue: 3;
Start page: 159;
Date: 2009;
Original page
ABSTRACT
In spite of the hope generated in these preliminarytrials which suggested RAAS immunization to be aninnovative and promising approach for the treatment ofhypertension, many questions remain unansweredregarding its efficacy, safety, appropriate dose selectionto achieve higher titer to achieve adequate BP loweringresponse, timing of administration and duration of responseand regarding its booster dose requirement. Thus, thesehurdles remain to be addressed before this strategy cancompete with current oral medications for hypertension.
Journal: JK Science : Journal of Medical Education & Research
ISSN 0972-1177
Volume: 11;
Issue: 3;
Start page: 159;
Date: 2009;
Original page
ABSTRACT
In spite of the hope generated in these preliminarytrials which suggested RAAS immunization to be aninnovative and promising approach for the treatment ofhypertension, many questions remain unansweredregarding its efficacy, safety, appropriate dose selectionto achieve higher titer to achieve adequate BP loweringresponse, timing of administration and duration of responseand regarding its booster dose requirement. Thus, thesehurdles remain to be addressed before this strategy cancompete with current oral medications for hypertension.
